VRNA

VRNA

USD

Verona Pharma plc American Depositary Share

$106.910+0.060 (0.056%)

Real-time Price

Healthcare
Biotechnology
United Kingdom

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$106.850

High

$106.910

Low

$106.910

Volume

1.87M

Company Fundamentals

Market Cap

9.1B

Industry

Biotechnology

Country

United Kingdom

Trading Stats

Avg Volume

1.69M

Exchange

NGM

Currency

USD

52-Week Range

Low $31.6Current $106.910High $106.93

Related News

Analyst Upgrades

Cantor Fitzgerald Suspends Overweight Rating on Verona Pharma PLC ADR, Maintains $100 Price Target

Cantor Fitzgerald suspends Overweight rating on Verona Pharma PLC ADR and Maintains $100 price target

View more
Cantor Fitzgerald Suspends Overweight Rating on Verona Pharma PLC ADR, Maintains $100 Price Target
BusinessWire

Merck Completes Acquisition of Verona Pharma

Acquisition strengthens Merck's cardio-pulmonary portfolio with addition of Ohtuvayre® (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade Merck (NYSE:MRK),

View more
Merck Completes Acquisition of Verona Pharma
GlobeNewswire

Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales

LONDON and RALEIGH, N.C., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on

View more
Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales
GlobeNewswire

Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

LONDON, U.K., and RALEIGH, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive

View more
Shareholders of Verona Pharma Approve Proposed Acquisition by Merck